ICON specialises in the planning management, execution, and analysis of Phase II-IIIb clinical trials, ranging from small studies to complex, multinational projects.
We provide customised services, which can be deployed on a stand alone basis or as part of an integrated “full-service” solution. These services can support both global and locally managed projects.